A listing of Cystic Fibrosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
You have probably heard about the pH levels of soils – if it is acidic or basic. Did you know that the human airway also has a measurement of its acidity and basicity, called airway pH? Researchers at Indiana University School of Medicine are researching how to identify the airway …
This is a two-part, multi-center, prospective longitudinal, exploratory study of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators and their impact in children with cystic fibrosis (CF) on endocrine growth factors and height, gastrointestinal function and gut microbiome, lung function and respiratory microbiome, liver and pancreatic function, sweat chloride, …
The purpose of this study is to evaluate the pharmacokinetics, safety, tolerability andy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in CF participants with at1 triple combination responsive (TCR) mutation in the cystic fibrosis transmembraneductance regulator (CFTR) gene.
What is the purpose of this study?The purpose of this study is to collect blood samples from people ages 5 years and older who are healthy volunteers or patients with CF or other pulmonary disorders. The blood samples will be used for a variety of studies related to CF, asthma, …
What is the purpose of this study?To compare the efficacy and safety of the BP relative to usual care (which includes CGM) in a 13-week randomized trial in individuals ≥ 14 years old with CFRD.To assess the sustainability of BP use, efficacy, and safety over an additional 13 weeks after …
This is a study to examine the effect of combining chronic oral azithromycin with inhaled tobramycin in adolescent and adult subjects with cystic fibrosis who are chronically infected with P. aeruginosa.
The purpose of this study is to evaluate the long-term safety and tolerability of TEZ/IVA in subjects with cystic fibrosis aged 6 years and older, who are homozygous or heterozygous for F508del mutation.
